Sugi Predict

Sugi Predict / Compounds / SCHEMBL1219954

SCHEMBL1219954

SCHEMBL1219954

CCOC(=O)N1CCC(O)CC1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.65
▸ L3MBTL1 Q9Y468 3/20 0.59
▸ THRB P10828 1/20 0.59
▸ ATM Q13315 1/20 0.59
▸ ALDH1A1 P00352 4/20 0.56
▸ NOS3 P29474 1/20 0.56
▸ NOS2 P35228 1/20 0.56
▸ TSHR P16473 1/20 0.55
▸ CHRM1 P11229 1/20 0.54
▸ HTT P42858 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ TDP1 Q9NUW8 2/20 0.50
▸ PKM P14618 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ BRD4 O60885 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18849447 0.93 GAA (0.57) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL4863171 0.93 GAA (0.57) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL3632401 0.89 GAA (0.54) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL8353063 0.89 CHRM1 (0.70) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL2360397 0.89 GAA (0.54) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL701943 0.88 GAA (0.56) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL2978403 0.88 GAA (0.56) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL12311386 0.86 GAA (0.50) GAAL3MBTL1THRBATMALDH1A1
Hydrochloric Acid SCHEMBL8307643 0.86 GAA (0.54) GAAL3MBTL1THRBATMALDH1A1
SCHEMBL1111736 0.85 GAA (0.67) GAAL3MBTL1THRBATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480521-B Full synthesis method of bepotastine besilate 成都丽凯手性技术有限公司 2024-04-16 — — CN claimed
CN-113480521-A Total synthesis method of bepotastine besilate 成都丽凯手性技术有限公司 2021-10-08 — — CN claimed
CN-107827810-B Synthesis method of N-ethoxycarbonyl-4-hydroxypiperidine 上海皓一生物科技有限公司 2021-01-22 — — CN claimed
US-12364659-B2 Multicomponent in situ coloration composition WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2025-07-22 — — US disclosed
US-20250114287-A1 COLOR COATINGS WITH DOWNSTREAM FEATURES HFC PRESTIGE SERVICE GERMANY GMBH (DE) 2025-04-10 — — US disclosed
US-12201714-B2 Multicomponent pur composition WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2025-01-21 — — US disclosed
WO-2024179393-A1 SULFOXIMINE COMPOUNDS AND APPLICATION THEREOF AS LRRK2 PROTEIN KINASE INHIBITORS 科辉智药(深圳)新药研究中心有限公司 2024-09-06 — — WO disclosed
US-20240261213-A1 MULTICOMPONENT PUR COMPOSITION Wella International Operations Switzerland Sárl (CH) 2024-08-08 — — US disclosed
US-12053542-B2 Multicomponent silicone composition WELLA INT OPERATIONS SWITZERLAND SARL (CH) 2024-08-06 — — US disclosed
CN-113480521-B Full synthesis method of bepotastine besilate 成都丽凯手性技术有限公司 2024-04-16 — — CN disclosed
CN-114805302-B Preparation method of 4- [ (4-chlorophenyl) -2-pyridylmethoxy ] -1-piperidine carboxylic ester 北京联本医药化学技术有限公司 2024-04-12 — — CN disclosed
EP-0282133-A2 1-alkyl substituted benzimidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-09-14 — — EP disclosed
EP-0134124-B1 PIPERIDINE DERIVATIVES FORDONAL, S.A. (ES) 1987-10-28 — — EP disclosed
US-4695575-A ANTIHISTAMINES JANSSEN PHARMACEUTICA, N.V. (BE) 1987-09-22 — — US disclosed
US-4550116-A ANTIALLERGENS, CARDIOVASCULAR AND RESPIRATORY DISORDERS FORDONAL, S.A. (ES) 1985-10-29 — — US disclosed
EP-0151826-A1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1985-08-21 — — EP disclosed
EP-0134124-A1 Piperidine derivatives FORDONAL, S.A. (ES) 1985-03-13 — — EP disclosed
US-4377578-A ANTIANAPHYLACTIC AGENTS, ANTIHISTAMINES JANSSEN PHARMACEUTICA, N.V. (BE) 1983-03-22 — — US disclosed
US-4250176-A BENZIMIDAZOLE-2-ONE, BENZOTHIAZOL-2-ONE, OR BENZOXAZOL-2-ONE SUBSTITUTIONS, ANTIANAPHALACTIC AGENTS, ANTIHISTAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1981-02-10 — — US disclosed
US-4200641-A ANTIANAPHYLACTIC AGENTS, ANTIHISTAMINES JANSSEN PHARMACEUTICA, N.V. (BE) 1980-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250114287-A1 COLOR COATINGS WITH DOWNSTREAM FEATURES KRT18, ITGA5, FLNA GAA 4258/4885L3MBTL1 4467/4885THRB 3175/4885
US-12053542-B2 Multicomponent silicone composition CUTA, CD99, PLOD3 GAA 4572/4885L3MBTL1 731/4885THRB 2178/4885
US-12364659-B2 Multicomponent in situ coloration composition KRT18, PRKDC, VIM GAA 4800/4885L3MBTL1 4354/4885THRB 3076/4885
US-12201714-B2 Multicomponent pur composition KRT18, EXOSC9, EXOSC4 GAA 4564/4885L3MBTL1 4295/4885THRB 3741/4885
US-20240261213-A1 MULTICOMPONENT PUR COMPOSITION KRT18, EXOSC9, EXOSC4 GAA 4564/4885L3MBTL1 4295/4885THRB 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.